Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
Molecular Cancer Therapeutics (2012) - Comments
pubmed: 22532603  doi: 10.1158/1535-7163.mct-11-0814  issn: 1538-8514  issn: 1535-7163 

Ali R. Jazirehi, James S. Economou